Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
EPCORITAMAB-BYSP 48MG INJ (CDM 430608359) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 16, 2026 , from http://ppman.hank.ai/transparency/procedure/430608359/by-state?code_type=CDM
“EPCORITAMAB-BYSP 48MG INJ (CDM 430608359) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/430608359/by-state?code_type=CDM. Accessed
November 16, 2026 .
“EPCORITAMAB-BYSP 48MG INJ (CDM 430608359) by State,” HANK Price Transparency ,
accessed November 16, 2026 ,
http://ppman.hank.ai/transparency/procedure/430608359/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
430608359 — Epcoritamab-bysp 48mg Inj
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$61,764
National median
$48,794 – $61,764
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 430608359 (CDM), with interquartile range
State Median p25 p75
AR $61,764 $48,794 $61,764